Skip to content

Ligation site of the inferior mesenteric vein in laparoscopic radical resection of rectal cancer: a multicenter randomized controlled study

A Multi-Center, Open-Label, Randomized, Parallel-Group, Superiority Comparative Study on the Short- and Long-term Outcomes of High Versus Low Ligation of the Inferior Mesenteric Vein in Laparoscopic Radical Resection of Rectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069149
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-10
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Experimental group:High ligation of the inferior mesenteric vein with left colic artery-preserving D3 lymph node dissection
Control group:Low ligation of the inferior mesenteric vein with left colic artery-preserving D3 lymph node dissection

Sponsors

The first Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 18–75 years old; 2. Patients diagnosed with malignant tumors confirmed by colonoscopic pathological biopsy and indicated for laparoscopic radical resection of rectal cancer; 3. Preoperative imaging revealing the clinical stage of the tumor to be Stage I (T2N0M0), II (T3-4N0M0), or III (T1-4N1M0 or T1-4N2M0) based on the American Joint Committee on Cancers (AJCC) TNM Staging System for Colorectal Cancer (Eighth edition, 2017); 4. Pelvic or rectal MRI to complete the evaluation of the clinical stage of the tumor; 5. American Society of Anesthesiologists grade I-III; 6. Patients or family members willing to participate and cooperate in the study.

Exclusion criteria

Exclusion criteria: 1. A history of other malignant tumors and abdominal vascular surgery; 2. Patients contraindicated for laparoscopic surgery (such as those with extensive adhesion caused by a previous major abdominal surgery or patients not suitable for pneumoperitoneum); 3. Patients with intestinal obstruction, perforation, or bleeding and other conditions requiring emergency surgery; 4. Pregnant or lactating women; 5. Patients who plan to participate in other clinical studies.

Design outcomes

Primary

MeasureTime frame
3-year disease-free survival rate;

Secondary

MeasureTime frame
Number of harvested lymph nodes;Operative time;Postoperative (within 30 days) morbidity and mortality;

Countries

China

Contacts

Public ContactXiaohui Du

The First Medical Center of Chinese PLA General Hospital

duxiaohui301@sina.com+86 10 6693 8326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026